Abstract
Objective
The objective of this study was to characterize the neonatal intensive care unit (NICU) course and outcomes for infants with neonatal-onset urea cycle disorders (UCDs).
Study design
Using the multicenter Children’s Hospitals Neonatal Database, a descriptive, retrospective cohort study was performed to characterize the presentation, interventions, comorbidities, and hospital outcomes for 176 patients with neonatal-onset UCDs that required level IV NICU care.
Results
The median age of presentation was 5 [3,7] days, with 167 (95%) infants requiring transfer to a level IV NICU. Renal replacement therapy was undertaken for at least 34 (20%) patients. Neurologic complications occurred most frequently, with 71 (40%) patients affected. Twenty-one (12%) infants experienced in-hospital mortality. Interventions, complications, and mortality were observed most frequently in the ornithine transcarbamylase deficiency group.
Conclusion
Neonatal-onset UCDs are associated with significant morbidity and mortality, but heterogeneity exists among the specific named UCDs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
References
Ah Mew N, Simpson KL, Gropman AL, Lanpher BC, Chapman KA, Summar ML. Urea cycle disorders overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al. editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle. Copyright © 1993–2024.
Häberle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42:1192–230.
Batshaw ML, Tuchman M, Summar M, Seminara J. A longitudinal study of urea cycle disorders. Mol Genet Metab. 2014;113:127–30.
Murthy K, Dykes FD, Padula MA, Pallotto EK, Reber KM, Durand DJ, et al. The Children’s Hospitals Neonatal Database: an overview of patient complexity, outcomes and variation in care. J Perinatol. 2014;34:582–6.
Summar ML, Dobbelaere D, Brusilow S, Lee B. Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr. 2008;97:1420–5.
Posset R, Garbade SF, Boy N, Burlina AB, Dionisi-Vici C, Dobbelaere D, et al. Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders—A successful strategy for clinical research of rare diseases. J Inherit Metab Dis. 2019;42:93–106.
Silvera-Ruiz SM, Arranz JA, Haberle J, Angaroni CJ, Bezard M, Guelbert N, et al. Urea cycle disorders in Argentine patients: clinical presentation, biochemical and genetic findings. Orphanet J Rare Dis. 2019;14:203.
Pontoizeau C, Roda C, Arnoux JB, Vignolo-Diard P, Brassier A, Habarou F, et al. Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders. Mol Genet Metab. 2020;130:110–7.
Posset R, Gropman AL, Nagamani SCS, Burrage LC, Bedoyan JK, Wong D, et al. Impact of diagnosis and therapy on cognitive function in urea cycle disorders. Ann Neurol. 2019;86:116–28.
Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD, et al. Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab. 2008;94:397–402.
Waisbren SE, Gropman AL, Batshaw ML. Improving long-term outcomes in urea cycle disorders—report from the Urea Cycle Disorders Consortium. J Inherit Metab Dis. 2016;39:573–84.
Gamal R, Khalifa O. Efficacy of peritoneal dialysis on encephalopathic patient with Citrullinemia type I. QJM-Int J Med. 2021;114:hcab096.
Celik M, Akdeniz O, Ozgun N. Efficacy of peritoneal dialysis in neonates presenting with hyperammonaemia due to urea cycle defects and organic acidaemia. Nephrology. 2019;24:330–5.
Bilgin L, Unal S, Gunduz M, Uncu N, Tiryaki T. Utility of peritoneal dialysis in neonates affected by inborn errors of metabolism. J Paediatr Child Health. 2014;50:531–5.
Hediger N, Landolt MA, Diez-Fernandez C, Huemer M, Haberle J. The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal onset urea cycle disorders. J Inherit Metab Dis. 2018;41:689–98.
Mattke AC, Shikata F, McGill J, Justo R, Venugopal P. Successful management of a neonate with OTC deficiency presenting with hyperammonemia and severe cardiac dysfunction with extracorporeal membrane oxygenation support and continuous renal replacement therapy. JIMD Rep. 2020;55:12–4.
Raturi S, Venkatesh IH, Nagesh NK, Venkatagiri P. Use of continuous hemodiafiltration for the treatment of a neonate with hyperammonemia secondary to argininosuccinate lyase (ASAL) deficiency. Indian J Pediatr. 2013;80:794–5.
Eminoglu FT, Oncul U, Kahveci F, Okulu E, Kraja E, Kose E, et al. Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders. Pediatr Nephrol. 2022;37:1387–97.
Raina R, Bedoyan JK, Lichter-Konecki U, Jouvet P, Picca S, Mew NA, et al. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy. Nat Rev Nephrol. 2020;16:471–82.
Ninkovic D, Mustapic Z, Bartonicek D, Benjak V, Cuk M, Buljevic AD, et al. The therapeutic hypothermia in the treatment of hyperammonemic encephalopathy due to urea cycle disorders and organic acidemias. Klin Padiatr. 2019;231:74–9.
Lichter-Konecki U, Nadkarni V, Moudgil A, Cook N, Poeschl J, Meyer MT, et al. Feasibility of adjunct therapeutic hypothermia treatment for hyperammonemia and encephalopathy due to urea cycle disorders and organic acidemias. Mol Genet Metab. 2013;109:354–9.
Birth Data 2022 [updated, Available from: https://www.cdc.gov/nchs/nvss/births.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fnchs%2Fbirths.htm.2025.
A Profile of Prematurity in the United States 2023 [updated cited 2023. Available from: https://www.marchofdimes.org/peristats/reports/united-states/prematurity-profile 2025.
Ewing AC, Ellington SR, Shapiro-Mendoza CK, Barfield WD, Kourtis AP. Full-term small-for-gestational-age newborns in the U.S.: characteristics, trends, and morbidity. Matern Child Health J. 2017;21:786–96.
Recommended Uniform Screening Panel [Available from: https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp 2024.
Merritt JL 2nd, Brody LL, Pino G, Rinaldo P. Newborn screening for proximal urea cycle disorders: current evidence supporting recommendations for newborn screening. Mol Genet Metab. 2018;124:109–13.
Ceyhan-Birsoy O, Machini K, Lebo MS, Yu TW, Agrawal PB, Parad RB, et al. A curated gene list for reporting results of newborn genomic sequencing. Genet Med. 2017;19:809–18.
Kido J, Matsumoto S, Häberle J, Inomata Y, Kasahara M, Sakamoto S, et al. Role of liver transplantation in urea cycle disorders: report from a nationwide study in Japan. J Inherit Metab Dis. 2021;44:1311–22.
García Vega M, Andrade JD, Morais A, Frauca E, Muñoz Bartolo G, Lledín MD, et al. Urea cycle disorders and indications for liver transplantation. Front Pediatr. 2023;11:1103757.
Pineda VL. Inherited Disorders of the Urea Cycle [updated 3/25/2019. Available from: https://www.aacc.org/science-and-research/clinical-chemistry-trainee-council/trainee-council-in-english/pearls-of-laboratory-medicine/2019/inherited-disorders-of-the-urea-cycle#:~:text=The%20incidence%20of%20Urea%20Cycle,11%25%20in%20later%20onset%20cases.
Bérat CM, Roda C, Brassier A, Bouchereau J, Wicker C, Servais A, et al. Enteral tube feeding in patients receiving dietary treatment for metabolic diseases: a retrospective analysis in a large French cohort. Mol Genet Metab Rep. 2021;26:100655.
Acknowledgement
Beverly Brozanski, Jacquelyn Evans, Theresa Grover, Karna Murthy, Michael Padula, Eugenia Pallotto, Anthony Piazza, Kristina Reber and Billie Short and ex officio David Durand, Francine Dykes, Jeanette Asselin, are executive members of the Children’s Hospitals Neonatal Consortium, Inc., who developed and manage the CHND (thechnc.org). For more information, please contact: exec@thechnc.org. We appreciate Mr. John Mallett and Ms. Evelyn Werbaneth’s contribution to study design and data analysis. We are indebted to the following CHNC participating institutions that serve the infants and their families; these institutions (and their site sponsors) also have invested in and continue to participate in the Children’s Hospitals Neonatal Database (CHND): Atlanta, Children’s Healthcare of Atlanta—Egleston (Anthony Piazza), Atlanta, Children’s Healthcare of Atlanta—Scottish Rite (Gregory Sysyn), Austin, Dell Children’s (Ashley Lucke, Molly Pont), Birmingham, Children’s of Alabama (Allison Black, Carl Coghill), Boston Children’s Hospital (Anne Hansen), Charlotte, Levine Children’s Hospital (Eugenia Pallotto), Chicago, Ann & Robert H. Lurie Children’s Hospital (Karna Murthy, Gustave Falciglia), Cincinnati Children’s Hospital (Beth Haberman), Cleveland Clinic (Tetyana Nesterenko), Columbus, Nationwide Children’s Hospital (Thomas Bartman), Dallas, Children’s Medical Center (Sushmita Yallapragada, Lina Chalak), Denver, Children’s Hospital Colorado (Danielle Smith, Stephanie Bourque), Detroit, Children’s Hospital Michigan (Girija Natarjan),Ft. Worth, Cook Children’s Healthcare System (Annie Chi, Yvette Johnson), Hartford, Connecticut Children’s (Annmarie Gotiolo), Houston, Texas Children’s Hospital (Lakshmi Katarkan, Kristina Reber), Indianapolis, Riley Children’s Health (Rebecca Rose), Iowa City, University of Iowa Stead Family Children’s Hospital (Julie Lindower), Kansas City, The Children’s Mercy Hospital (Julie Weiner), Little Rock, Arkansas Children’s (Laura Carroll), Los Angeles Children’s Hospital (Rachel Chapman), Madison, American Family Children’s Hospital (Nina Menda), Memphis, Le Bonheur Children’s Hospital (Mark Weems), Minneapolis, Children’s Minnesota (Ann Downey), Milwaukee, Wisconsin Children’s Hospital (Joanne Lagatta), Oakland, UCSF Benioff Children’s Hospital (Priscilla Joe), Oklahoma Children’s Hospital (Trent Tipple, Patricia Williams), Omaha Children’s Hospital (Nicole Birge), Orange County, Children’s Hospital of Orange County (Michel Mikhael), Orlando, AdventHealth for Children (Narendra Dereddy, Rajan Wadhawan), Orlando, Nemours Children’s Hospital (Aaron Weiss), Philadelphia, Children’s Hospital of Philadelphia (Michael Padula), Philadelphia, St. Christopher’s Hospital for Children (Vilarmis Quinones), Phoenix Children’s Hospital (Pam Griffiths), Pittsburgh Children’s Hospital (Toby Yanowitz, Abeer Azzuqa), Rochester, MN, Mayo Clinic Children’s (Ellen Bendel-Stenzel), Salt Lake City, Primary Children’s Hospital (Con Yee Ling), San Diego, Rady Children’s Hospital (Mark Speziale), Seattle Children’s Hospital (Robert DiGeronimo, Elizabeth Jacobsen), St. Louis Children’s Hospital (Beverly Brozanski, Rakesh Rao), St Paul, Children’s Minnesota (Ann Downey), St. Petersburg, All Children’s Hospital (Linda Van Marter), Toronto, The Hospital for Sick Children (Kyong-Soon Lee), Washington, Children’s National Hospital (Billie Lou Short), Wilmington, Nemours/Alfred I. duPont Hospital for Children (Kevin Sullivan), Winston-Salem, Brenner Children’s Hospital (Cherrie Welch).
Author information
Authors and Affiliations
Contributions
Whitney Thompson conceptualized and designed the study, performed data analysis, drafted the initial manuscript, and critically reviewed and revised the manuscript. Ellen Bendel-Stenzel and Kristen Suhrie conceptualized and designed the study, performed data analysis, and critically reviewed and revised the manuscript. Isabella Zaniletti contributed to the design of the study, collected data, performed the initial statistical analyses, and critically reviewed and revised the manuscript. Theresa Grover, Karna Murthy, and Michael Padula contributed to the design of the study, performed data analysis, and critically reviewed and revised the manuscript. Queenie Tan performed data analysis and critically reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
KRS has received honoraria from Illumina for a speaking engagement. WST serves on the Clinical Advisory Board for Inflection Medicine and is engaged in a know-how agreement with the company. The other authors have no competing interests to disclose.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Thompson, W.S., Bendel-Stenzel, E.M., Zaniletti, I. et al. A multicenter descriptive study of neonatal-onset urea cycle disorder patients hospitalized in level IV NICUs. J Perinatol (2026). https://doi.org/10.1038/s41372-025-02557-x
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41372-025-02557-x

